Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04038151 · ClinicalTrials.gov registry record · NA

Intuitive Control of a Hybrid Prosthetic Leg During Ambulation

A NA study of Amputation, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04038151 is a NA study of Amputation that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 20 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04038151, a NA study of Amputation, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The objective of this research is to determine the clinical benefits of an innovative and lightweight powered leg controlled using our intent recognition framework in laboratory and community environments.

Conditions Studied

Interventions

  • DEVICE Hybrid Leg
  • DEVICE Prescribed Passive Prosthesis

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2018-12-01
Est. Completion 2025-06-30
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT04038151

The ClinicalTrials.gov registry entry for NCT04038151 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 2 interventions - of which Hybrid Leg is the first listed.

NCT04038151 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04038151 about?

NCT04038151 is a clinical study titled "Intuitive Control of a Hybrid Prosthetic Leg During Ambulation". The objective of this research is to determine the clinical benefits of an innovative and lightweight powered leg controlled using our intent recognition framework in laboratory and community environments.

What is the current status of trial NCT04038151?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2018-12-01. Estimated completion is 2025-06-30.

What conditions does trial NCT04038151 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT04038151?

The interventions under investigation include: Hybrid Leg (DEVICE), Prescribed Passive Prosthesis (DEVICE).

Who is sponsoring clinical trial NCT04038151?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04038151 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.